PURETECH HEALTH PLC - ADR (PRTC) Forecast, Price Target & Analyst Ratings

NASDAQ:PRTCUS7462371060

Current stock price

15.545 USD
+0.04 (+0.29%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PURETECH HEALTH PLC - ADR (PRTC).

Forecast Snapshot

Consensus Price Target

Price Target
$70.07
+ 350.75% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 23, 2026

ChartMill Buy Consensus

Rating
84.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$70.07
Upside
+ 350.75%
From current price of $15.55 to mean target of $70.07, Based on 5 analyst forecasts
Low
$69.38
Median
$70.07
High
$72.13

Price Target Revisions

1 Month
0.00%
3 Months
3.40%

Price Target Summary

5 Wall Street analysts provided a forecast for the next 12 months for PRTC. The average price target is 70.07 USD. This implies a price increase of 350.75% is expected in the next year compared to the current price of 15.545.
The average price target has been revised upward by 3.4% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

PRTC Current Analyst RatingPRTC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5

Analyst Ratings History

PRTC Historical Analyst RatingsPRTC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 1 2 3 4 5

Analyst Ratings Consensus

ChartMill Buy Consensus
84.00%
PRTC was analyzed by 5 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about PRTC.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed PRTC. So this is just the average opinion of a couple of analysts.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-08-25Piper SandlerMaintains Overweight
2022-08-09SVB LeerinkMaintains Outperform
2022-06-15SVB LeerinkMaintains Outperform
2022-01-07SVB LeerinkMaintains Outperform
2021-08-25SVB LeerinkMaintains Outperform
2021-05-27Peel Hunt LLPReiterate Buy
2021-04-15Liberum CapitalReiterate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 23, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates 2025 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
PRTC revenue by date.PRTC revenue by date.
15.618M
-10.19%
3.33M
-78.68%
4.828M
44.98%

-100.00%
65.246M889.61M
1,263.47%
1.786B
100.76%
EBITDA
YoY % growth
PRTC ebitda by date.PRTC ebitda by date.
-188.914M
-32.12%
-141.266M
25.22%
-132.524M
6.19%
-140.592M
-6.09%
-150.793M
-7.26%
-162.004M
-7.43%
-120.291M
25.75%
N/AN/A
EBIT
YoY % growth
PRTC ebit by date.PRTC ebit by date.
-197.807M
-31.63%
-146.199M
26.09%
-136.095M
6.91%
-145.642M
-7.01%
-155.843M
-7.00%
-166.953M
-7.13%
-125.846M
24.62%
N/AN/A
Operating Margin
PRTC operating margin by date.PRTC operating margin by date.
-1,266.53%-4,390.36%-2,818.87%N/AN/AN/A-192.88%N/AN/A
EPS
YoY % growth
PRTC eps by date.PRTC eps by date.
N/A
23.94%
N/A
-55.91%
-4.27
50.95%
-6.01
-40.93%
-6.51
-8.33%
-6.92
-6.15%
-7.94
-14.77%
N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PRTC Yearly Revenue VS EstimatesPRTC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2028 2029 2030 500M 1B 1.5B
PRTC Yearly EPS VS EstimatesPRTC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -2 -4 -6 -8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-17.46%
EPS Next 5 Year
-16.78%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
223.14%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-5.38%
EBIT Next 5 Year
3.12%

PURETECH HEALTH PLC - ADR / PRTC Forecast FAQ

What do analysts expect the price target to be for PURETECH HEALTH PLC - ADR (PRTC)?

5 analysts have analysed PRTC and the average price target is 70.07 USD. This implies a price increase of 350.75% is expected in the next year compared to the current price of 15.545.

When does PURETECH HEALTH PLC - ADR (PRTC) report earnings?

PURETECH HEALTH PLC - ADR (PRTC) will report earnings on 2026-04-23, after the market close.

How many analysts have analysed PURETECH HEALTH PLC - ADR (PRTC)?

The number of analysts covering PURETECH HEALTH PLC - ADR (PRTC) is 5.